by Mark Derewicz, University of North Carolina at Chapel Hill School of Medicine Patient with Myasthenia Gravis. Credit: Cumulus at Dutch Wikipedia, CC BY-SA 3.0 , via Wikimedia Commons The Lancet Neurology has published data from the phase 3 MycarinG study evaluating the efficacy and safety of rozanolixizumab in adult patients with acetylcholine receptor autoantibody-positive (AChR-Ab+) or muscle-specific...
